Acrivon Therapeutics Eulerpool News

Acrivon Therapeutics Eulerpool News

Acrivon Therapeutics Stock News

Acrivon Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Acrivon Therapeutics news here.

• August 16 ·

  TipRanks
  Acrivon Therapeutics: A Buy Rating Justified by Clinical Advances and Financial Stability
• August 15 ·

  Yahoo
  Are Medical Stocks Lagging Acrivon Therapeutics, Inc. (ACRV) This Year?
• August 14 ·

  TipRanks
  Acrivon Therapeutics, Inc.: A Promising Buy Amidst Clinical Advancements and Robust Pipeline Developments
• August 14 ·

  TipRanks
  Acrivon Therapeutics, Inc.: A Strong Buy on Robust Clinical Prospects and Financial Stability
• August 13 ·

  InvestorPlace
  ACRV Stock Earnings: Acrivon Therapeutics Beats EPS for Q2 2024
• August 13 ·

  TipRanks
  Promising Acrivon Trial Results and Market Opportunity Support Buy Rating
• August 13 ·

  Yahoo
  Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
• August 13 ·

  TipRanks
  Buy Rating Affirmed on Acrivon Therapeutics Amid Anticipated Clinical Updates and Novel Treatment Approaches
• August 13 ·

  Seeking Alpha
  Acrivon Therapeutics GAAP EPS of -$0.52
• August 13 ·

  Thefly.com
  Acrivon Therapeutics sees cash runway into 2H26